Off-label immunotherapy for advanced cancer
Part of Cancer clinical trials.
This trial tests immunotherapy drugs (checkpoint inhibitors) that are not officially approved for your specific cancer but may help fight it. The goal is to see if these off-label treatments are safe and effective for a wide range of cancer types.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a type of cancer for which your doctor wants to try an immunotherapy drug that is not officially approved for that cancer
- Your overall health is reasonably good - you can manage your daily activities with little or no help
- Your blood counts and liver/kidney function are within adequate limits as checked by standard tests
- If you can become pregnant, you are not pregnant and will use effective birth control during the study and for 6 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well immunotherapy (a type of cancer treatment that helps your immune system attack cancer cells) works for people with various types of cancer. You may join if you are already planning to receive this treatment, and the study will track your outcomes to help improve future care.
This study looks at how people’s bodies respond to cancer immunotherapy and why some people get side effects. Your information and lab results may help improve how immunotherapy is managed in the future.
This study is looking at how well combining immunotherapy with radiation therapy works for people with various types of cancer. It aims to see how effective and safe the treatment is, and what factors might influence outcomes.
This study looks at how common medicines might interact with immunotherapy (a treatment that helps your immune system fight cancer). Participation could help doctors learn how to better manage side effects and dosing for patients on these treatments.
This Phase 1 trial tests a new drug called IUAb190708 designed to help your immune system fight advanced or recurrent solid cancers. The study will evaluate its safety, how your body handles it, and whether it works against your tumor.
This trial tests a combination of two investigational drugs (IMM2510 and IMM01) that work with your immune system to fight cancer. It may help people with advanced solid tumors who have not responded to other treatments.
Hear when a new Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.